Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

Research Institute of the McGill University Health Centre

$253,576.00

Regulation of TGF-beta action in chondrocytes: Role of ALK1-endoglin interplay

EF 2010-11

Résumé
Arthritis is a serious medical problem affecting a large majority of the population and has limited options for treatment. Symptoms including pain, joint inflammation and swelling have adverse effects on joint mobility and a significant impact on quality of life. Although the cause of arthritis in not known, several studies suggest that abnormal transforming growth factor-beta (TGF-beta) is involved in arthritis. TGF-beta is produced by most cells of the body and plays an important role in the development and maintenance of healthy cartilage. However, abnormal TGF-beta action in the joints can lead to several problems including cartilage destruction leading to osteoarthritis or other joint diseases. Our research goals are to understand the biology of TGF-beta in human cartilage cells (chondrocytes) and to uncover how deregulated TGF-beta action is involved in arthritic conditions. The proposed research may lead to the development of new therapies for the treatment these conditions.
Programme
Operating Grant
Emplacement
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
225735
Name
Philip Anie
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Clinical Investigation - B: Arthritis, Bone, Skin and Cartilage
Projecttitle
Regulation of TGF-beta action in chondrocytes: Role of ALK1-endoglin interplay
Programtype2
Operating Grants
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$253,576
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Alk1; Animal Model; Arthritis; Cartilage; Cartilage Regeneration; Chondrocytes; Endoglin; Osteoarthritis; Receptors; Tgf-Beta
Abstract
Arthritis is a serious medical problem affecting a large majority of the population and has limited options for treatment. Symptoms including pain, joint inflammation and swelling have adverse effects on joint mobility and a significant impact on quality of life. Although the cause of arthritis in not known, several studies suggest that abnormal transforming growth factor-beta (TGF-beta) is involved in arthritis. TGF-beta is produced by most cells of the body and plays an important role in the development and maintenance of healthy cartilage. However, abnormal TGF-beta action in the joints can lead to several problems including cartilage destruction leading to osteoarthritis or other joint diseases. Our research goals are to understand the biology of TGF-beta in human cartilage cells (chondrocytes) and to uncover how deregulated TGF-beta action is involved in arthritic conditions. The proposed research may lead to the development of new therapies for the treatment these conditions.
Competitiondate
201103
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Philip, Anie
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $253,576~ $0~